FILKRI
NDC 69448-009, filgrastim-laha, injection, solution, from Accord BioPharma Inc.,.
- Product NDC
- 69448-009
- Status
- Listed
- Labeler
- Accord BioPharma Inc.,
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761027
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69448-009 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FILGRASTIM480 ug/.8mL
Pharmacologic classes
Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69448-009-03 | 69448000903 | 10 SYRINGE in 1 BOX (69448-009-03) / .8 mL in 1 SYRINGE |
| 69448-009-63 | 69448000963 | 1 SYRINGE in 1 BOX (69448-009-63) / .8 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/9c2f9573-08fd-43be-a489-8a5e5d8ab2ff
Use it
Look up 69448-009 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69448-009 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69448-009. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.